Company intelligence / Profile preview

Covis Pharma

Zug, Zug, Switzerland

Ownership: Private
Employees: ~1222
Development stage: Commercial

Overview

Covis Pharma markets a broad portfolio of specialty pharmaceutical products for chronic and life-threatening conditions. The company has expanded through acquisitions, including AMAG Pharmaceuticals and several branded drugs from AstraZeneca. Its marketed products include Alvesco® (asthma), Omnaris®/Zetonna® (allergic rhinitis), Makena® (preterm birth prevention), Feraheme® (iron deficiency anemia), among others. Some controversy surrounds Makena®, which the FDA recommended for withdrawal due to efficacy concerns.

Therapeutic areas: PulmonologyCardiovascularWomen's HealthHematologyRare Diseases
Modalities: small moleculesinhaled therapeutics
Industry: Biotech

Drug pipeline

4 assets

aclidinium bromide

Commercial

Indications: Pulmonary/Respiratory Diseases

3 more assets in the full pipeline.

Request access →

Partnerships

AstraZenecaSanofiGlaxoSmithKlinecontract manufacturing organizations.

Beyond the preview

Go deeper on Covis Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Covis Pharma.

Explore the full profile